The baroreceptor reflex mediated heart rate response is generally estimated by complex cross-spectral analysis (transfer function gain) between R-R interval and systolic blood pressure (SBP) fluctuations in the low frequency (LF, 0.04 -0.15 Hz) band: the baroreceptor reflex sensitivity (BRS, ms/mmHg) (Andriessen, P. et al. Pediatr Res 2003;53:89 -97).
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REDUCTION OF URINARY PGE2 INDUCED BY IBUPROFEN TREATMENT IN PRETERM INFANTS WITH PATENT DUCTUS ARTERIOSUS.
DEPARTMENT OF PEDIATRICS & CLINICAL MEDICINE-SECTION OF NEONATAL INTENSIVE CARE UNIT, UNIVERSITY OF CAGLIARI , 2 DEPARTMENT OF MEDICINE & PUBLIC HEALTH-SECTION OF PHARMACOL-OGY, UNIVERSITY OF VERONA (ITALY)
Background: Patent ductus arteriosus (PDA) is a common finding among preterm infants. Hemodynamically significant PDA requires medical treatment with cyclooxygenase inhibitors such as indomethacin or ibuprofen (IBU). IBU has been shown to be as effective as indomethacin in ductal closure, with fewer adverse effects.
Aim: To investigate urinary excretion changes of PGE2 induced by IBU treatment in preterm infants with PDA.
Methods: Twenty preterm infants (gestational age, 24 to 32 weeks; birth weight, 640 to 1820 g) with a significant PDA at 48 -72 hours of age were enrolled. Two serial urine samples were noninvasively collected in each patient, by a cotton wool ball method, just before and 12-24 hours after a conventional course of IBU treatment, respectively. Urinary PGE2 concentrations were measured by a sensitive and accurate enzyme immunoassay (EIA) method (Cayman Chem, Ann Arbor, MI, USA). Furthermore, serum creatinine and other renal function parameters were assessed before and after IBU treatment.
Results: Mean urinary PGE2 concentrations decreased significantly after IBU treatment (from baseline values of 66.95ϩ/-16.78 to 27.15ϩ/-17.92 pg/mL, PϽ0.001). Post-treatment urinary levels of PGE2 particularly low (Ͻ5 pg/mL) were found in two patients, who developed clinically relevant manifestations (intraventricular hemorrhage, acute renal failure, and intestinal perforation). Serum creatinine concentration increased from baseline value in 7 of 20 patients, 4 of them having an increase of Ͼ20%, after IBU treatment.
Conclusions: The adverse effects of cyclooxygenase inhibitors may involve different organs of newborn, but particularly the kidney, which is considered prostaglandin-dependent. Although IBU represents the most safe drug in ductal closure, it induced a significant reduction of urinary PGE2 concentrations in our study population. In newborns with relevant side effects this reduction was dramatic. Further studies are needed to confirm these data and to determine whether urinary PGE2 may represent an index of toxicity in clinical settings.
RENAL PGE2 IN PRETERM INFANTS: A POSSIBLE ROLE IN THE ADAP-TATION TO EXTRAUTERINE LIFE
R. ANTONUCCI 1 , L. CUZZOLIN 2 , A. ARCERI 1 , V. FANOS 1 1
DEPARTMENT OF PEDIATRICS & CLINICAL MEDICINE-SECTION OF NEONATAL INTENSIVE CARE UNIT, UNIVERSITY OF CAGLIARI , 2 DEPARTMENT OF MEDICINE & PUBLIC HEALTH-SECTION OF PHARMACOL-OGY, UNIVERSITY OF VERONA (ITALY)
Background: Prostanoids contribute to important changes during transition from fetal to newborn life. In particular, PGE2 play a crucial role in protecting the immature kidney from high levels of angiotensin II.
Aim: To measure urinary PGE2 excretion in preterm neonates of different G.A. at birth, since there is evidence that PGE2 concentrations in urine reflect predominantly their renal generation and then could be correlated with kidney maturation or renal problems.
Methods: Thirty-eight preterm infants admitted to the neonatal intensive care unit at the University of Cagliari, Italy, were divided in three groups according to their G.A.: Group A (nϭ9, mean G.A. 27.6ϩ/-1.7 wks, mean B.W. 1013ϩ/-340 g); Group B (nϭ19, mean G.A. 30.8ϩ/-0.8 wks, mean B.W. 1529ϩ/-468 g); Group C (nϭ10, mean G.A. 34.4ϩ/-1.3 wks, mean B.W. 2056ϩ/-515 g). None of the neonates had been asphyxiated at birth and none had a specific renal abnormality or other clinical conditions influencing renal function. Spot urine samples, collected on days 2-3 of life, were analyzed for PGE2 using a commercially available kit (Cayman Chem, Ann Arbor, MI, USA).
Results: By comparing PGE2 concentrations among the three groups with ANOVA test (Group A: 65.67ϩ/-12.97 pg/ml; Group B: 77.84ϩ/-11.46 pg/ml; Group C: 51.90ϩ/-11.49 pg/ml), a statistically significant difference was observed (Fϭ16.01, pϽ0.001). Moreover, in neonates of groups A and B with a G.A. Ͻ33 weeks, a positive linear correlation was found between PGE2 values and G.A. (rϭ0.53, pϭ0.003).
Conclusions: From our data, the higher PGE2 values observed in neonates where nephrogenesis was not completed (G.A. Ͻ33 wks) could be due to an altered passive reabsorption of PGE2 along the nephron because of kidney immaturity or could reflect a mechanism of protection for these neonates at higher risk to develop renal problems. 
INDIVIDUALIZED FORTIFICATION OF HUMAN MILK: DOES IT MAKE THE DIFFERENCE?
CENTERFOR INFANT NUTRITION, DIVISION OF NEONATOLOGY,MACEDONIO MELLONI HOSPITAL (ITALY), 2 FOMON INFANT NUTRI-TION UNIT, DEPARTMENT OF PEDIATRICS, UNIVERSITY OF IOWA (USA)
Background: Inadequate nutrition leading to growth failure is common among premature infants. Although fortified breast milk is the preferred feeding, nutrient intakes achieved with fortified breast milk fall short of meeting nutrient needs consistently. This is mainly due inadequate protein content of fortifiers and high inter-and intra-individual variation in composition of expressed breast milk.
Objective: To test a new adjustable fortification regimen designed to ensure that protein needs of premature infants are met all the time. The new regimen encompassed increasing the amount of fortifier and the addition of extra protein to breast milk. These periodic adjustments of fortification were guided by determinations of BUN. The study tested the hypothesis that the new regimen leads to higher protein intake and to improved weight gain compared to standard fortification.
Methods: In a prospective, controlled trial, preterm infants with birth weights of 600-1750 grams and gestational ages between 26 -34 weeks were fed their own mother's milk, or banked donor milk, or both. Infants were randomly assigned to either the new (adjustable) fortification regimen or the standard regimen. The study period began when feeding volume reached 150 ml/kg/day and ended when infants reached 2000 g. The standard fortification regimen (STD) consisted in the addition of the recommended amount of HMF. The adjustable regimen (ADJ) consisted of standard fortification, but with addition of extra HMF and supplemental protein guided by twice-weekly BUN determinations. Primary outcome was growth, serum biochemical indicators and nutrient intakes were secondary outcomes.
Results: Thirty-two infants completed the study as planned (16 ADJ, 16 STD) . Infants receiving the ADJ regimen had mean protein intakes of 2.9, 3.2, 3.4 g/kg/d, respectively, in weeks 1, 2 and 3, whereas infants receiving the STD regimen had intakes of 2.9, 2.9, 2.8 g/kg/d, respectively. Infants on the ADJ regimen showed significantly greater gain in weight (17.5 Ϯ 3.0 g/kg/d vs 14.4 Ϯ 3.0 g/kg/d, pϽ0.01) and greater gain in head circumference (1.4 Ϯ 0.3 vs 1.0 Ϯ 0.3; pϽ0.05) than infants on the STD regimen. Weight and head circumference gain were significantly correlated with average protein intake (rϭ0.39, pϽ0.05 for both). No significant correlations were found between growth parameters and intake of fat and energy. In the ADJ group BUN concentrations increased significantly (pϽ0.001) over time but were not significantly higher than in the STD group.
Conclusion: Premature infants managed with the new adjustable fortification regimen had significantly higher weight and head circumference gains than infants managed with standard fortification. Higher protein intake appears to have been primarily responsible for the improved growth with the adjustable regimen. With the new regimen protein intakes approached intrauterine accretion rates without evidence of metabolic stress. The new fortification method seems to be a promising approach to solving the problem of undernutrition among premature infants fed human milk.
